Another patient with T1N2M0 triple-negative primary breast cancer was classified as having HER2-positive breast cancer because lymph node and breast tumor recurrence at 1 year were HER2 positive based on fluorescence in situ hybridization (FISH) findings. The gene discussed is ERBB2; the disease is breast cancer.